{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpoliticos-pulse-check.simplecast.com%2Fepisodes%2Fthe-astrazenecatasrophe-continues-F2yrT_o2","width":444,"version":"1.0","type":"rich","title":"The AstraZeneCatasrophe continues","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/4da913b0-f9d2-4c36-aafd-0cefba14ffbc/53dd2434-9a18-4ec1-b716-3a0d79d20428/politico-pulse-check-audio-audio.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/b59b6fcd-4687-409f-a9ed-763520199b90\" height=\"200\" width=\"100%\" title=\"The AstraZeneCatasrophe continues\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Last week, it was fears of blood clots in the EU. This week, it’s claims of cherry-picking efficacy data in the US. POLITICO's Sarah Owermohle talks with Dispatch's Jeremy Siegel about AstraZeneca's transcontinental confidence crisis."}